GeminIQ Website Logo

Viewing HRGN free

Subscribe for full history, 90+ metrics, screener, watchlist...

Harvard Apparatus Regenerative Technology, Inc.

HRGN

Subscribe to unlock 17+ years of data

Financial Statements

Values in Millions ($)
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial
Subscriber-only column
Assets Current
Assets Current
112212341112
Assets
Cash And Cash Equivalents At Carrying Value
001112240000
Short Term Investments
-----------1
Accounts Receivable Net Current
00000000-000
Inventory Net
000000000000
Prepaid Expense And Other Assets Current
000000000000
Property Plant And Equipment Net
000000000000
Operating Lease Right Of Use Asset
000000000000
Deferred Costs
------0--11-
Prepaid Expense Noncurrent
111111111111
Assets
223323454434
Liabilities And Stockhold…
Accounts Payable Current
100000011100
Accrued Liabilities And Other Liabilities
-------11101
Liabilities Current
Contract With Customer Liability
---------0--
Liabilities Current
322111112211
Contract With Customer Liability Current
1000000-----
Notes Payable Current
0000000-----
Operating Lease Liability Current
000000000000
Operating Lease Liability Noncurrent
000000000-00
Liabilities
322111112-11
Common Stock Value
000000000000
Stockholders Equity
Additional Paid In Capital
10810810710610410310310296949393
Stockholders Equity
-10121234-0023
Retained Earnings Accumulated Deficit
-110-108-107-105-103-101-100-98-96-94-92-90
Accumulated Other Comprehensive Income Loss Net Of…
-0-0-0-0-0-0-0-0-0-00-
Liabilities And Stockholders Equity
223323452234
Common Stock Par Or Stated Value Per Share
0.010.010.010.010.010.010.010.010.010.010.010.01
Temporary Equity Par Or Stated Value Per Share
----------0.010.01
Common Stock Shares Authorized
606060606060606060606060
Common Stock Shares Issued
181818171616161614141414
Temporary Equity Shares Authorized
----------00
Temporary Equity Shares Issued
----------00
Shares Outstanding
181818171616161614141414
Temporary Equity Shares Outstanding
----------00

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Custom Table

0/5
Search a metric to start building a table

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Interactive Financial Visualizations

0/1
Search a metric to start building a visual

Subscribe to unlock 17+ years of data

Earnings Market Reaction

Fiscal Year
Q1 1 Month
Q1 2 Month
Q1 3 Month
Q2 1 Month
Q2 2 Month
Q2 3 Month
Q3 1 Month
Q3 2 Month
Q3 3 Month
Q4 1 Month
Q4 2 Month
Q4 3 Month
2026-28.00%-30.67%-30.67%---------
20250.00%-5.56%-24.44%22.73%33.57%34.97%-7.00%-6.80%-9.00%-6.26%-10.55%-35.60%
20248.62%25.00%7.76%119.27%80.45%68.18%-10.56%-10.33%-10.40%-1.04%-14.51%-17.62%
2023---25.32%49.87%51.90%-14.02%-26.33%-33.39%-22.67%-23.33%-12.33%

Earnings Market Reaction data beyond 3 years is for subscribers only.

Unlock the full earnings market reaction history

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
2025-03-31
2024-12-31
2024-09-30
2024-06-30
2024-03-31
2023-12-31
2023-09-30
Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only column

Metric history beyond 3 years is for subscribers only.

Unlock 17+ years of history across 90+ calculated metrics

Start 7-day free trial
Subscriber-only column
Liquidity Ratios
Current Ratio
0.26
0.53
1.19
1.86
0.91
1.93
3.17
3.19
0.33
0.28
0.81
1.79
Quick Ratio
0.15
0.27
0.90
1.57
0.69
1.52
2.75
2.98
0.24
0.20
0.67
1.62
Working Capital
-2.25M
-778.00K
295.00K
751.00K
-114.00K
1.11M
2.21M
2.73M
-1.34M
-1.62M
-185.00K
835.00K
Leverage & Debt
Debt to Equity
-2.22
18.54
1.53
0.64
1.81
0.67
0.38
0.38
-6.97
12.80
0.59
0.39
Interest Coverage TTM
-516.15
-856.38
-864.38
-822.75
-395.71
-237.90
-203.32
-221.32
-305.92
-902.67
-
-
Debt Ratio
1.82
0.95
0.61
0.39
0.64
0.40
0.27
0.28
0.45
0.50
0.37
0.28
Efficiency & Turnover
Asset Turnover TTM
0.51
0.34
0.20
0.19
0.21
0.11
0.12
0.05
0.04
0.04
0.04
0.01
Days Sales Outstanding TTM
2.60
4.12
64.03
0.98
2.69
4.80
99.74
3.11
-
15.97
14.17
27.38
Receivables Turnover TTM
140.29
88.50
5.70
371.50
135.80
76.00
3.66
117.50
-
22.86
25.75
13.33
Per Share Metrics
Diluted EPS TTM
-
-
-
-
-
-
-
-0.55
-0.56
-0.58
-0.67
-0.63
Free Cash Flow Per Share TTM
-0.21
-0.23
-0.23
-0.25
-0.27
-0.29
-0.33
-0.33
-0.47
-0.49
-0.52
-0.54
Dividend Per Share TTM
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Margin Metrics
Gross Profit Margin TTM
7.54%
7.46%
8.24%
16.29%
14.58%
30.38%
37.21%
54.89%
77.31%
-
-
-
Operating Profit Margin TTM
-683.30%
-774.12%
-982.24%
-885.87%
-990.72%
-1,764.35%
-1,796.74%
-3,484.68%
-3,682.41%
-5,077.50%
-8,728.16%
-21,637.50%
Net Profit Margin TTM
-680.55%
-769.60%
-975.71%
-878.33%
-984.68%
-1,761.00%
-1,798.14%
-3,495.32%
-3,689.35%
-5,051.25%
-8,759.22%
-21,940.00%
Growth Metrics
Net Revenue Growth (1Y)
44.62%
111.72%
63.72%
216.17%
214.35%
161.25%
317.48%
487.50%
-
-
-
-
Net Income Growth (1Y)
-0.04%
-7.47%
-11.16%
-20.55%
-16.10%
-8.92%
-14.30%
-6.40%
-3.92%
14.70%
44.28%
-16.78%
EPS Growth (1Y)
-9.49%
-16.22%
-20.45%
-29.95%
-24.85%
-20.20%
-22.03%
-13.48%
-7.10%
0.38%
21.70%
-30.37%
Valuation Metrics
P/E TTM
-3.37
-4.33
-4.42
-5.17
-4.05
-4.17
-5.70
-10.38
-5.23
-5.18
-7.44
-8.48
P/B TTM
-16.32
320.47
28.75
21.70
35.56
15.00
13.68
22.21
-143.62
239.10
40.79
27.40
P/S TTM
22.92
33.31
43.17
45.39
39.86
73.50
102.49
362.98
192.82
261.51
651.88
1,860.20
Market Cap
22.50M
29.48M
30.39M
33.73M
27.06M
30.72M
44.07M
85.30M
41.65M
41.84M
67.14M
74.41M
Enterprise Value
22.20M
29.18M
29.22M
32.41M
26.34M
29.15M
41.84M
81.71M
41.51M
41.57M
66.71M
74.14M
Calculated Values
Free Cash Flow TTM
-3.64M
-4.01M
-3.83M
-4.29M
-4.30M
-4.65M
-4.85M
-4.95M
-6.63M
-6.89M
-6.95M
-7.47M
Net Debt
-305.00K
-304.00K
-1.17M
-1.32M
-723.00K
-1.57M
-2.23M
-3.59M
-139.00K
-272.00K
-432.00K
-269.00K
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of data

Insider Transactions

2025-11-25Purchase
Owner: He, Junli
Title: CEO
Shares: 3,000
Price/Share: $1.70
Value: $5,100.00
Shares Owned: 280,575
Relationship: Director,Officer
Ownership: Direct
2025-09-30Purchase
Owner: He, Junli
Title: CEO
Shares: 300
Price/Share: $1.98
Value: $594.00
Shares Owned: 277,575
Relationship: Director,Officer
Ownership: Direct
2025-09-02Purchase
Owner: He, Junli
Title: CEO
Shares: 11,225
Price/Share: $1.85
Value: $20,766.25
Shares Owned: 277,275
Relationship: Director,Officer
Ownership: Direct
2025-08-21Purchase
Owner: He, Junli
Title: CEO
Shares: 4,050
Price/Share: $1.72
Value: $6,966.00
Shares Owned: 266,050
Relationship: Director,Officer
Ownership: Direct
2024-12-24Purchase
Owner: He, Junli
Title: CEO
Shares: 2,299
Price/Share: $2.87
Value: $6,598.13
Shares Owned: 262,000
Relationship: Director,Officer
Ownership: Direct

Subscribe to unlock 17+ years of data

Institutional Ownership

No data available for chart
2022-06-30
0.12%
Inst. Shares: 13,383
Shares Outstanding: 11,230,525
2022-03-31
0.14%
Inst. Shares: 15,433
Shares Outstanding: 10,761,861
2021-12-31
0.18%
Inst. Shares: 18,433
Shares Outstanding: 10,062,432
2021-09-30
0.18%
Inst. Shares: 18,433
Shares Outstanding: 10,014,494
2021-06-30
0.26%
Inst. Shares: 25,000
Shares Outstanding: 9,688,407

Harvard Apparatus Regenerative Technology, Inc. (HRGN) — SEC Financial Statements & Analysis

Harvard Apparatus Regenerative Technology, Inc. (HRGN) is a surgical & medical instruments & apparatus company, incorporated in DE. Harvard Apparatus Regenerative Technology, Inc. trades on OTC as: HRGN. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Harvard Apparatus Regenerative Technology, Inc. reported a 44.62% year-over-year revenue growth, a Gross Profit Margin of 7.54% (TTM), a Debt-to-Equity ratio of -2.22x, a Price-to-Sales (P/S) ratio of 22.92x (TTM), a Price-to-Book (P/B) ratio of -16.32x (TTM), at a market cap of $22.50M. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y
44.62%
Gross Profit Margin TTM
7.54%
Debt To Equity
-2.22x
P/S TTM
22.92x
P/B TTM
-16.32x
Market Cap
$22.50M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Harvard Apparatus Regenerative Technology, Inc. in?

Harvard Apparatus Regenerative Technology, Inc. (HRGN) operates in the Surgical & Medical Instruments & Apparatus industry.

What is HRGN's market cap?

Harvard Apparatus Regenerative Technology, Inc. (HRGN) has a market capitalization of $22.50M as of 2026-06-30.

What exchange does HRGN trade on?

Harvard Apparatus Regenerative Technology, Inc. (HRGN) trades on the OTC.

Where is Harvard Apparatus Regenerative Technology, Inc. incorporated?

Harvard Apparatus Regenerative Technology, Inc. is incorporated in DE.

Wall Street's data.
Main Street's price.